Sibeprenlimab (VIS649) is a humanized IgG 2 monoclonal antibody that suppresses APRIL. Sibeprenlimab has an inhibitory effect on APRIL and may be studied for the prevention and treatment of kidney disease (IgAN).
CAS Number:
[2382896-07-1]
Target:
VIS-649 , VIS649
* VAT and and shipping costs not included. Errors and price changes excepted